Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion type Assertion NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_head.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion description "[Overall, 9 (26%) of 34 cases (2 severely atypical dysplastic nevi, 2 moderately atypical dysplastic nevi, and 5 mildly atypical dysplastic nevi) exhibited the BRAFV600E mutation (P = .22), with lack of IGFBP7 expression in 4 (44.4%) of 9 cases (1 severely atypical, 1 moderately atypical, and 2 mildly atypical); and 25 (73.5%) of 34 cases (9 severely atypical, 9 moderately atypical, and 7 mildly atypical) were BRAFWT, with enhanced IGFBP7 expression in 12 (48%) of 25 cases (6 severely atypical, 3 moderately atypical, and 3 mildly atypical).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_provenance.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion evidence source_evidence_literature NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_provenance.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion SIO_000772 20233623 NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_provenance.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion wasDerivedFrom befree-20140225 NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_provenance.
- NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_assertion wasGeneratedBy ECO_0000203 NP686348.RA-ZfYlYbLMre2oI-ambHO8WmYHCuKdZNCr16KCJ1Rriw130_provenance.